Noradrenaline and movement initiation disorders in parkinson’s disease: a pharmacological functional mri study with clonidine

HIGHLIGHTS

• who: Marion Criaud et al. from the Institute of Psychiatry Psychology and Neuroscience, Department Child and Adolescent Psychiatry, Kings College London, London , QR, UK have published the research: Noradrenaline and Movement Initiation Disorders in Parkinsonu2019s Disease: A Pharmacological Functional MRI Study with Clonidine, in the Journal: Cells 2022, 2640 of 12/07/2022
• what: The analysis focused on the pre-stimulus period, while other events were considered as events of non-interest in the statistical analysis. This study provides pharmacological functional MRI evidence that noradrenaline contributes to movement initiation via the modulation of the u03b12 . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.